A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery

Inclusion Criteria: * Subjects must be able to understand and sign the informed consent form and be able to follow the study procedures. * Male or female subjects over 40 years of age who are scheduled to undergo cataract phacoemulsification surgery combined with intraocular lens implantation. Exclusion Criteria: * Known hypersensitivity to dexamethasone or any component of the Dexycu. * History of intraocular inflammation of any cause in either eye, presence of corneal abnormalities or malnutrition. * Have high intraocular pressure, with an IOP(intraocular pressure) of \> 21 mmHg in the test eye at screening, regardless of whether receiving anti-glaucoma monotherapy therapy. * Posterior capsule rupture or lens dislocation, anterior vitreal membrane rupture, vitreous prolapse and intraoperative floppy iris syndrome during cataract surgery. * Other conditions that the investigator considers inappropriate to participate the study.